Furthermore, we directly evaluated the therapeutic effect of GSDMD inhibition on UPEC-induced orchitis in a mouse model by administering DMF, an inhibitor of GSDMD activation that has been approved for the treatment of multiple sclerosis (Narapureddy and Dubey, 2019). The gene discussed is GSDMD; the disease is orchitis.